SOLUTIONS > Generating Real-World Evidence
GENERATING
REAL-WORLD EVIDENCE
Oncology is a complicated landscape to navigate. Since provinces administer healthcare independent of each other, there is no unified data source; therefore, creating a lack of research-ready real-world data. The time delays and inadequate datasets of other real-world data (RWD) sources limits the value of real-world evidence (RWE) studies. The real-world data (RWD) collected through our Personalize My Treatment (PMT) databank is built for research, allowing you to quickly draw meaningful insights from Canada’s geographic, demographic, and social diversity.
EXACTIS’ REAL-WORLD DATA SETS CAN HELP YOU:
- Mine and leverage data to enable clinical trials
- Identify patients in specific centres based on specified clinical/molecular characteristics
- Create synthetic control arms using RWD
- Real-world evidence data gathering and analysis
- Validate real-world effectiveness of new treatments
- To assess and support formulary listings or expansions
- Measure value-based agreements
- Provide Canadian insights for health economic models
- Clinical data mining to address treatment gaps and opportunities for improvement
- Assess and support new therapeutic combinations or indications
- Assess standard-of-care treatment patterns and identify gaps
- Provide Canadian insights into molecular epidemiology and diagnostic landscape
- Special Access Program and Compassionate Use Program value-add data management and data analysis
- Develop curated data solutions for outcome based agreements (OBAs)
EXACTIS’ REAL-WORLD EVIDENCE TEAM CAN HELP:
- Identify, clarify, and address your research questions
- Protocol design and study start-up
- Project Management
- Electronic data capture and integration
- Statistical analysis and reporting
- Analyze real-world data (RWD) with you or on your behalf
- Access to insights from Canadian oncology KOLs
- Navigate the research process with you from initial study concept through presentation or publications of your study findings
- Publications
“Sermonix is honoured to collaborate with Exactis Innovation, a truly esteemed international centre of excellence in precision medicine. Our ELAINE trials are solely focused on women with ESR1 mutations, for whom there is such great need of targeted treatments that potentially can prolong and enhance their lives. Working with Exactis furthers that mission.”